Cooper Financial Group Bristol Myers Squibb CO Transaction History

Cooper Financial Group

$670 Million
Q2 2024

A detailed history of Cooper Financial Group transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cooper Financial Group holds 18,768 shares of BMY stock, worth $998,269. This represents 0.12% of its overall portfolio holdings.

Number of Shares

18,768

Previous 21,996 14.68%

Holding current value

$998,269

Previous $1.19 Million 34.65%

% of portfolio

0.12%

Previous 0.2%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$40.25 - $52.99 $129,927 - $171,051	-3,228 Reduced 14.68%	18,768 $779,000
Q1 2024 Apr 11, 2024	BUY	$47.98 - $54.4 $121,821 - $138,121	2,539 Added 13.05%	21,996 $1.19 Million
Q4 2023 Jan 16, 2024	BUY	$48.48 - $57.85 $23,706 - $28,288	489 Added 2.58%	19,457 $998,000
Q3 2023 Oct 13, 2023	BUY	$57.89 - $64.73 $23,561 - $26,345	407 Added 2.19%	18,968 $1.1 Million
Q2 2023 Jul 07, 2023	BUY	$63.71 - $70.74 $184,313 - $204,650	2,893 Added 18.46%	18,561 $1.19 Million
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $69,718 - $79,076	1,061 Added 7.26%	15,668 $1.09 Million
Q4 2022 Jan 13, 2023	BUY	$68.48 - $81.09 $97,447 - $115,391	1,423 Added 10.79%	14,607 $0
Q3 2022 Oct 13, 2022	BUY	$0.13 - $76.84 $268 - $158,981	2,069 Added 18.61%	13,184 $937,000
Q2 2022 Jul 11, 2022	BUY	$72.62 - $79.98 $121,202 - $133,486	1,669 Added 17.67%	11,115 $856,000
Q1 2022 Apr 12, 2022	BUY	$61.48 - $73.72 $20,411 - $24,475	332 Added 3.64%	9,446 $690,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $64,195 - $74,836	-1,197 Reduced 11.61%	9,114 $568,000
Q3 2021 Oct 06, 2021	BUY	$59.17 - $69.31 $25,975 - $30,427	439 Added 4.45%	10,311 $610,000
Q2 2021 Jul 12, 2021	BUY	$61.91 - $67.42 $4,828 - $5,258	78 Added 0.8%	9,872 $660,000
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $213,920 - $240,597	-3,605 Reduced 26.9%	9,794 $618,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $197,528 - $223,836	3,421 Added 34.29%	13,399 $831,000
Q3 2020 Oct 09, 2020	BUY	$57.43 - $63.64 $7,121 - $7,891	124 Added 1.26%	9,978 $602,000
Q2 2020 Jul 15, 2020	BUY	$54.82 - $64.09 $230,518 - $269,498	4,205 Added 74.44%	9,854 $579,000
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $48,720 - $70,801	1,050 Added 22.83%	5,649 $315,000
Q4 2019 Jan 07, 2020	BUY	$49.21 - $64.19 $226,316 - $295,209	4,599 New	4,599 $295,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Cooper Financial Group with notifications on news.

Account

Cooper Financial Group Bristol Myers Squibb CO Transaction History